Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) saw unusually-high trading volume on Monday . 15,000 shares were traded during trading, an increase of 107% from the previous session’s volume of 7,235 shares.The stock last traded at $7.99 and had previously closed at $8.00.
Oxford BioMedica Stock Performance
The company has a 50-day moving average of $8.19 and a 200-day moving average of $8.96.
About Oxford BioMedica
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
Featured Articles
- Five stocks we like better than Oxford BioMedica
- Vertex’s Crinetics Deal Balances Growth with Integration Risk
- Stacking Chips: The Hidden Supply Shock Fueling Intel
- Drone Stocks Are Down, But Defense Backlogs Tell a Different Story
- Industrials Are Leading in 2026, But These ETFs Take Different Routes
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
